Cardiology

ACC: Niacin/Laropiprant no benefit in vascular disease

(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious side effects, according ...

Medical research

Study sheds light on side effects of COX-2 drugs

It's been about a decade since the promise of COX-2 inhibitors—drugs that relieve arthritis pain and inflammation without the gastrointestinal side effects of other painkillers—was tempered by the realization that they ...

Diseases, Conditions, Syndromes

MERS virus in Saudi poses hospital threat: study

The deadly MERS coronavirus which has emerged in Saudi Arabia poses a threat to hospitals because it spreads rapidly and carries a high mortality rate, according to a study out Thursday.

page 6 from 7